Beryl Drugs Ltd.
|
Ratio Analysis
|
|
You can view the
Ratio Analysis
for the last 5 years.
Market Cap. (Rs.)
|
8.87 Cr.
|
P/BV
|
1.00
|
Book Value (Rs.)
|
17.55
|
52 Week High/Low (Rs.)
|
46/17
|
FV/ML
|
10/1
|
P/E(X)
|
11.54
|
Bookclosure
|
30/09/2024
|
EPS (Rs.)
|
1.52
|
Div Yield (%)
|
0.00
|
|
Months | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | PR | PR |
FaceValue | 10.00 | 10.00 |
| | |
PER SHARE RATIOS | | |
| | |
Basic EPS (Rs.) | 1.96 | 0.00 |
Diluted EPS (Rs.) | 1.96 | 0.00 |
| | |
PROFITABILITY RATIOS | | |
| | |
PBDIT Margin (%) | 10.56 | 1.89 |
PBIT Margin (%) | 8.50 | -1.38 |
PBT Margin (%) | 7.67 | -3.12 |
Net Profit Margin (%) | 6.21 | -3.59 |
NP After MI And SOA Margin (%) | 6.21 | -3.59 |
| | |
COVERAGE RATIOS | | |
| | |
Interest Coverage Ratio (%) | 10.28 | -0.79 |
Interest Coverage Ratio (Post Tax) (%) | 8.50 | -1.06 |